financial post
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
Financial Post • 1 YEAR AGO
IMF, World Bank brace for potential breakup with U.S. under Trump’s ‘America First’ agenda
Financial Post • 1 YEAR AGO
Add an extra layer of protection to your devices with this all-in-one security solution
Financial Post • 1 YEAR AGO
Tensions rise on Nova Scotia river as Indigenous eel fishers reject Ottawa rules
Financial Post • 1 YEAR AGO